Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3128171
Max Phase: Preclinical
Molecular Formula: C45H48N8O4
Molecular Weight: 764.93
Molecule Type: Small molecule
Associated Items:
ID: ALA3128171
Max Phase: Preclinical
Molecular Formula: C45H48N8O4
Molecular Weight: 764.93
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc(-c2ncc(-c3ccc4[nH]c([C@@H]5CCCN5C(=O)[C@@H](c5ccccc5)N(C)C)nc4c3)o2)cc1)c1ccccc1
Standard InChI: InChI=1S/C45H48N8O4/c1-50(2)39(29-13-7-5-8-14-29)44(55)52-25-11-17-36(52)41-48-34-24-21-32(27-35(34)49-41)38-28-46-43(57-38)31-19-22-33(23-20-31)47-42(54)37-18-12-26-53(37)45(56)40(51(3)4)30-15-9-6-10-16-30/h5-10,13-16,19-24,27-28,36-37,39-40H,11-12,17-18,25-26H2,1-4H3,(H,47,54)(H,48,49)/t36-,37-,39+,40+/m0/s1
Standard InChI Key: KZUJWSNYJOUTAI-HTNZGVODSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 764.93 | Molecular Weight (Monoisotopic): 764.3799 | AlogP: 7.08 | #Rotatable Bonds: 11 |
Polar Surface Area: 130.91 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.91 | CX Basic pKa: 7.27 | CX LogP: 5.28 | CX LogD: 4.90 |
Aromatic Rings: 6 | Heavy Atoms: 57 | QED Weighted: 0.14 | Np Likeness Score: -1.09 |
1. Belema M, Nguyen VN, Romine JL, St Laurent DR, Lopez OD, Goodrich JT, Nower PT, O'Boyle DR, Lemm JA, Fridell RA, Gao M, Fang H, Krause RG, Wang YK, Oliver AJ, Good AC, Knipe JO, Meanwell NA, Snyder LB.. (2014) Hepatitis C virus NS5A replication complex inhibitors. Part 6: Discovery of a novel and highly potent biarylimidazole chemotype with inhibitory activity toward genotypes 1a and 1b replicons., 57 (5): [PMID:24437689] [10.1021/jm4016203] |
2. Ivachtchenko AV, Mitkin OD, Yamanushkin PM, Kuznetsova IV, Bulanova EA, Shevkun NA, Koryakova AG, Karapetian RN, Bichko VV, Trifelenkov AS, Kravchenko DV, Vostokova NV, Veselov MS, Chufarova NV, Ivanenkov YA.. (2014) Discovery of novel highly potent hepatitis C virus NS5A inhibitor (AV4025)., 57 (18): [PMID:25148100] [10.1021/jm500951r] |
Source(1):